Send the following on WhatsApp
Continue to Chat對付棘手的移植後 CMV 感染,Takeda 旗下 Livtencity 獲歐盟核准上市 https://geneonline.news/ec-approves-takeda-cmv-drug-livtencity/?variant=zh-cn
對付棘手的移植後 CMV 感染,Takeda 旗下 Livtencity 獲歐盟核准上市 https://geneonline.news/ec-approves-takeda-cmv-drug-livtencity/?variant=zh-cn